MIRAGRON S 50/5: Effective Mirabegron 50mg & Solifenacin 5mg for OAB

Jun 18, 2024

MIRAGRON S 50/5 

Mirabegron (ER) (50mg) and Solifenacin succinate (5mg)

MIRAGRON S 50/5 combines two powerful medications, Mirabegron (50mg extended-release) and Solifenacin Succinate (5mg), to effectively treat overactive bladder (OAB) symptoms. This article provides comprehensive information on the benefits, usage, dosage, side effects, precautions, and other essential details to ensure optimal understanding and effective use of this combination therapy.

Uses of Mirabegron (ER) (50mg) and Solifenacin Succinate (5mg)

  • Treatment of Overactive Bladder (OAB): This combination is used to manage symptoms of OAB, including urinary urgency, urinary frequency, and urge incontinence.
  • Improvement of Bladder Control: By combining Mirabegron’s ability to relax the bladder muscle with Solifenacin’s action on the bladder’s smooth muscle, this medication improves overall bladder control.

How Do Mirabegron and Solifenacin Work?

Mirabegron

Mirabegron is a beta-3 adrenergic agonist that relaxes the detrusor muscle in the bladder. This relaxation increases bladder capacity and reduces the frequency of involuntary bladder contractions, helping to manage OAB symptoms effectively.

Solifenacin Succinate

Solifenacin Succinate is an antimuscarinic agent that works by inhibiting muscarinic receptors in the bladder.

Dosage and Administration

  • Recommended Dose: The typical dose is one tablet of MIRAGRON S 50/5 taken once daily.
  • Administration: Drink a full glass of water orally when taking the tablet. You can take it with or without meals. Do not chew, crush, or break the tablet—instead, swallow it whole.
    missing Dosage: Take the missing dose as soon as you remember it. If the next dose is soon due, skip the missed one and carry on with the usual plan. Never take two doses to make up for one that you missed.

Side Effects

While MIRAGRON S 50/5 is generally well-tolerated, it may cause some side effects. It is important to be aware of these and consult a healthcare provider if they occur.

  • Common Side Effects:

  • Serious Side Effects:

    • Severe allergic reactions (e.g., rash, itching, swelling, severe dizziness)
    • Severe hypertension (high blood pressure)
    • Angioedema (swelling under the skin)
    • Rapid or irregular heartbeat

If any serious side effects occur, seek immediate medical attention.

Precautions and Warnings

  • Allergic Reactions: Inform your healthcare provider if you have a history of allergic reactions to Mirabegron, Solifenacin, or any other medications.
  • Blood Pressure: Mirabegron can increase blood pressure. 
  • Kidney and Liver Function: Use with caution in patients with impaired kidney or liver function, as dosage adjustments may be necessary.
  • Pregnancy and Breastfeeding: The safety of this combination in pregnant or breastfeeding women has not been fully established. Use only if the potential benefits outweigh the risks.
  • Interaction with Other Medications: Inform your healthcare provider about all medications, supplements, and herbal products you are taking to avoid potential interactions.

Drug Interactions

MIRAGRON S 50/5 can interact with other medications, affecting their efficacy or increasing the risk of side effects. Notable interactions include:

  • Anticholinergic Drugs: Combining with other anticholinergic medications may enhance the risk of urinary retention and dry mouth.
  • Beta-blockers: Concurrent use with beta-blockers may affect heart rate and blood pressure.
  • CYP3A4 Inhibitors: Solifenacin is metabolized by the CYP3A4 enzyme, so inhibitors of this enzyme can increase Solifenacin levels, potentially leading to increased side effects.

Monitoring and Follow-Up

Regular monitoring is essential to ensure the effectiveness and safety of this combination therapy.

  • Blood Pressure: Regularly monitor blood pressure to detect any increases that may occur due to Mirabegron.
  • Symptom Relief: Monitor the improvement in OAB symptoms and report any persistent or worsening symptoms to your healthcare provider.
  • Kidney and Liver Function: Periodic blood tests may be necessary to assess kidney and liver function, especially in patients with pre-existing conditions.

Conclusion

Mirabegron (ER) (50mg) and Solifenacin Succinate (5mg), marketed as MIRAGRON S 50/5, provide an effective combination therapy for managing overactive bladder symptoms. By combining the relaxing effects of Mirabegron on the bladder muscle with the inhibitory effects of Solifenacin on bladder spasms, this medication offers comprehensive relief from OAB symptoms. However, it is crucial to use this medication under the guidance of a healthcare provider, considering the potential side effects and drug interactions. Regular monitoring and follow-up are essential to ensure safe and effective treatment. If you have any questions or concerns about this medication, consult your healthcare provider for personalized advice and information. Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. Based in Navi Mumbai, the company holds certifications from WHO, GMP, and ISO, underscoring its commitment to quality and safety. Sterispharma is dedicated to providing high-quality drugs at affordable prices across India, strictly adhering to WHO guidelines. Sterispharma offers the convenience of an online pharmacy, enabling customers to easily purchase medicines and benefit from home delivery. The company's mission is to supply a wide array of healthcare products to meet the diverse needs of the medical community. Whether it's advanced treatments, medications for rare conditions, or essential health necessities, Sterispharma strives to serve the broad demands of the healthcare industry. If you need medicine then you can order it on these two websites sterisonline and sterispharma  Order Now Sterispharma's extensive product lineup includes treatments for various health areas such as Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology.

For further information:

 Email: info@sterispharma.com / contact@sterispharma.com

 Call/WhatsApp: 7877551268, 7849827488

  Buy Now

SHARE WITH